FundedIQ
Biotechnology

Neurona Therapeutics: Funding, Investors & Team (Oct 2026)

Neurona Therapeutics is a biotechnology company in the pre-clinical stage, founded by four neuroscientists and stem cell pioneers from The University of California, San Francisco. The company is dedicated to creating and developing cell-based therapies for treating challenging neurological diseases. Their primary goal is to create therapeutic formulations of a specific type of nerve cell for direct delivery to damaged areas of the nervous system. Drawing from nearly two decades of research, they believe that certain subgroups of neurons possess the unique ability to mend and restore malfunctioning neural networks. The company's team of skilled scientists, scientific advisors, and board members are working diligently to expedite the development of groundbreaking treatments for patients facing significant medical challenges.

www.neuronatherapeutics.com LinkedIn San Francisco, United States 101-250 employees
Total raised
$289M
Rounds
6
Latest
Undisclosed round
Jun 2025

Neurona Therapeutics has raised $289M across 6 funding rounds on record, the most recent an undisclosed round of $14.0M announced in Jun 2025.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Neurona Therapeutics Company Profile and Key Stats

Total funding raised
$289M
across 6 rounds on record
Funding rounds on record
6
Latest funding round
Undisclosed round
$14.0M in Jun 2025
Employees
101-250
reported band
Headquarters
San Francisco, United States

Latest funding round on record: Jun 2025.

Neurona Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$14.0M
Undisclosed round
$102M
Undisclosed round
$3.8M
Series E
$120M
Grant
$8.0M
Undisclosed round
$41.5M

Neurona Therapeutics raised $41.5M in an undisclosed round announced in Jun 2021.

11 months later, a Grant of $8.0M was announced in May 2022.

1.8 years later, a Series E of $120M was announced in Feb 2024.

7 months later, an undisclosed round of $3.8M was announced in Sep 2024.

7 months later, an undisclosed round of $102M was announced in Apr 2025.

2 months later, an undisclosed round of $14.0M was announced in Jun 2025.

Neurona Therapeutics Founders and Leadership Team

Name
Role
Contact
Arnold Kriegstein
Founder
—
Cory R Nicholas
Founder
—
Cory Nicholas
CEO
—

No contact details are on record for this team yet.

Neurona Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Neurona Therapeutics' latest round of $14.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Neurona Therapeutics in Biotechnology and San Francisco

Companies Similar to Neurona Therapeutics

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Neurona Therapeutics Funding FAQs

What does Neurona Therapeutics do?

Neurona Therapeutics is a biotechnology company in the pre-clinical stage, founded by four neuroscientists and stem cell pioneers from The University of California, San Francisco. The company is dedicated to creating and developing cell-based therapies for treating challenging neurological diseases. Their primary goal is to create therapeutic formulations of a specific type of nerve cell for direct delivery to damaged areas of the nervous system. Drawing from nearly two decades of research, they believe that certain subgroups of neurons possess the unique ability to mend and restore malfunctioning neural networks. The company's team of skilled scientists, scientific advisors, and board members are working diligently to expedite the development of groundbreaking treatments for patients facing significant medical challenges.

How much funding has Neurona Therapeutics raised?

Neurona Therapeutics has raised $289M across 6 rounds on record. The most recent is an undisclosed round of $14.0M announced in Jun 2025.

When did Neurona Therapeutics last raise funding?

Neurona Therapeutics' most recent funding round on record is an undisclosed round of $14.0M, announced in Jun 2025.

Who founded Neurona Therapeutics?

FundedIQ lists Arnold Kriegstein (Founder), Cory R Nicholas (Founder) at Neurona Therapeutics.

Who is the CEO of Neurona Therapeutics?

Cory Nicholas is listed as CEO at Neurona Therapeutics.

Where is Neurona Therapeutics headquartered?

Neurona Therapeutics is based in San Francisco, California, United States.

How many employees does Neurona Therapeutics have?

Neurona Therapeutics is in the 101-250 employee band.

How does Neurona Therapeutics' funding compare to other Biotechnology startups?

Neurona Therapeutics' latest round of $14.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Neurona Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neurona Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.